 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CytoDyn, Inc. is a clinical-stage biotechnology company, which focuses on the clinical development of innovative treatments for multiple therapeutic indications based on its product candidate, leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5. Its pipeline includes Leronlimab Clinical Development Pipeline and Long-Acting CCR5 Inhibitor Development Pipeline. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA.

Watchers	5,966
52-Wk Low	$0.1456
52-Wk High	$0.48

Market Cap	$200.39M
Volume (M)	816,684.00
52-Wk High	$0.48
52-Wk Low	$0.1456

Current Price	$0.2328
Prev Close	$0.2151
Open	$0.2175
Dividend Yield	0.00%
50-Day Moving Average	$0.1729
Beta	1.11
Avg. Volume	1.72M
PE Ratio	-2.74

52-Week High	$0.48
52-Week Low	$0.1456
Market Capitalization	$200.39M
EPS	-$0.0851
Price to Book	-1.85
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-6.21

CYDY CytoDyn Inc

About

Feed

News

Earnings

Fundamentals